TickerWise

BNT — Brookfield Wealth Solutions Ltd.

$37.96+0.03%

Last close: · regular session

Last 60 sessions

BNT closed at $37.96 (+0.03%) on Oct 26, 2026. Float: 60.6M shares. Latest SEC filing: 6-K on Aug 13, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for BNT in the TickerWise workspace.

Brookfield Reinsurance Ltd., through its subsidiaries, provides insurance and reinsurance services to individuals and institutions in the United States, Canada, and internationally. The company operates in three segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT). The Direct Insurance segment offers a range of insurance products and services including Whole, Universal, Variable Universal, and Credit Life insurance products; deferred, single premium immediate, and variable annuities; primary and excess casualty products, such as specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product liability, environmental liability, and auto liability; professional liability including management, transaction, and errors and omissions liability; property insurance for homeowners and renters, inland marine, and auto physical damages; surety, animal mortality, and ocean marine insurance; and health insurance, credit insurance, and pension products. The Reinsurance segment provides reinsurance of annuity-based products, such as fixed, fixed index, and payout annuities. The PRT segment provides transfer by a corporate sponsor of the risks associated with the sponsorship and administration of a pension plan. The company was formerly known as Brookfield Asset Management Reinsurance Partners Ltd. and changed its name to Brookfield Reinsurance Ltd. in December 2022. Brookfield Reinsurance Ltd. was incorporated in 2020 and is headquartered in Pembroke, Bermuda.

Company profile

Latest SEC filings for BNT

Related companies

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.